PTAB Grants Petitioner Celltrion’s Motion To Submit Supplemental Information In Tocilizumab IPR

The U.S. Patent Trials & Appeals Board (Board) recently issued an Order … IPRs brought by Celltrion against tocilizumab-related patents.